We observed that COVID-19 patients with increased levels of pGSN/IL-6, pGSN/HGF and pGSN/IgM compared with the other markers are more likely not to progress to severe disease and will eventually be discharged alive (Figure 6A;Supplementary Figure S5A). This evidence concerns the gene IL6 and COVID-19.